Discoveries and Treatments for Brain Conditions

Brain conditions, including Parkinson’s disease, stroke, epilepsy and mental illness, are chronic afflictions that diminish a person’s quality of life. The conditions affect one in five Americans. The social and economic impacts are devastating, with annual U.S. health care and lost productivity costs estimated at nearly $500 billion.

MnDRIVE Brain Conditions was established in 2013. MnDRIVE is a landmark partnership between the University and the state of Minnesota. Discoveries and treatments for brain conditions, a MnDRIVE core area of research and partnership, addresses complex and debilitating nervous system-related disorders by leveraging university and state investments in medicine and engineering and extending our vibrant partnerships with medical device industries in Minnesota. ​​​​​​

Through high-impact research and discovery in the field of neuromodulation, MnDRIVE trains the next generation of scientists and clinicians, and brings new and improved therapies to Minnesotans suffering from brain conditions and nervous systems disorders/deficits. The initiative will expand University partnerships with industries to bring neuromodulation innovations to market, which benefits patients and advances the state’s economy.

MnDRIVE Brain Conditions is a multidisciplinary team involving six faculty members from different departments within the University of Minnesota who serve on our Steering Committee. Dr. Timothy Ebner is the chair of this executive team.